Mawer Investment Management Ltd. Abbott Laboratories Transaction History

Mawer Investment Management Ltd.

$19 Billion
Q2 2025

A detailed history of Mawer Investment Management Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Mawer Investment Management Ltd. holds 1,185,658 shares of ABT stock, worth $160 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

1,185,658

Previous 1,311,221 9.58%

Holding current value

$160 Million

Previous $174 Million 7.29%

% of portfolio

0.85%

Previous 0.87%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$123.95 - $138.08 $15.6 Million - $17.3 Million	-125,563 Reduced 9.58%	1,185,658 $161 Million
Q1 2025 May 07, 2025	SELL	$111.1 - $140.22 $4.99 Million - $6.29 Million	-44,886 Reduced 3.31%	1,311,221 $174 Million
Q4 2024 Feb 12, 2025	SELL	$111.93 - $119.39 $4.89 Million - $5.21 Million	-43,679 Reduced 3.12%	1,356,107 $153 Million
Q3 2024 Nov 07, 2024	SELL	$100.07 - $118.13 $2.44 Million - $2.88 Million	-24,407 Reduced 1.71%	1,399,786 $160 Million
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $2.95 Million - $3.29 Million	-29,247 Reduced 2.01%	1,424,193 $148 Million
Q1 2024 May 06, 2024	SELL	$109.52 - $120.96 $9.07 Million - $10 Million	-82,800 Reduced 5.39%	1,453,440 $165 Million
Q4 2023 Feb 07, 2024	BUY	$90.19 - $110.4 $45 Million - $55.1 Million	499,022 Added 48.11%	1,536,240 $169 Million
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $29.1 Million - $35 Million	304,954 Added 41.65%	1,037,218 $100 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $2.46 Million - $2.75 Million	24,449 Added 3.45%	732,264 $79.8 Million
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $33.1 Million - $39 Million	342,231 Added 93.61%	707,815 $71.7 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $239,741 - $281,253	2,522 Added 0.69%	365,584 $40.1 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $2.74 Million - $3.18 Million	-28,354 Reduced 7.24%	363,062 $35.1 Million
Q2 2022 Aug 09, 2022	BUY	$102.07 - $123.37 $623,341 - $753,420	6,107 Added 1.58%	391,416 $42.5 Million
Q1 2022 May 06, 2022	SELL	$114.02 - $139.04 $5.74 Million - $7.01 Million	-50,385 Reduced 11.56%	385,309 $45.6 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $11 Million - $13.5 Million	95,570 Added 28.1%	435,694 $61.3 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $133,925 - $148,160	1,148 Added 0.34%	340,124 $40.2 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $35.9 Million - $42.2 Million	338,976 New	338,976 $39.3 Million

Others Institutions Holding ABT

# of Institutions

3,600

Shares Held

1.4B

Call Options Held

9.23M

Put Options Held

8.1M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $236B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mawer Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mawer Investment Management Ltd. with notifications on news.

Account

Mawer Investment Management Ltd. Abbott Laboratories Transaction History